CA2717481A1 - Procedes pour inhiber la croissance de cellules tumorales a l'aide d'inhibiteurs de la pompe a protons - Google Patents

Procedes pour inhiber la croissance de cellules tumorales a l'aide d'inhibiteurs de la pompe a protons Download PDF

Info

Publication number
CA2717481A1
CA2717481A1 CA2717481A CA2717481A CA2717481A1 CA 2717481 A1 CA2717481 A1 CA 2717481A1 CA 2717481 A CA2717481 A CA 2717481A CA 2717481 A CA2717481 A CA 2717481A CA 2717481 A1 CA2717481 A1 CA 2717481A1
Authority
CA
Canada
Prior art keywords
cancer
tumor
lansoprazole
pharmaceutically acceptable
proton pump
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2717481A
Other languages
English (en)
Inventor
Bassam Damaj
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nexmed Holdings Inc
Original Assignee
Bio Quant Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Quant Inc filed Critical Bio Quant Inc
Publication of CA2717481A1 publication Critical patent/CA2717481A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2717481A 2008-03-04 2008-03-04 Procedes pour inhiber la croissance de cellules tumorales a l'aide d'inhibiteurs de la pompe a protons Abandoned CA2717481A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/002918 WO2009110862A1 (fr) 2008-03-04 2008-03-04 Procédés pour inhiber la croissance de cellules tumorales à l'aide d'inhibiteurs de la pompe à protons

Publications (1)

Publication Number Publication Date
CA2717481A1 true CA2717481A1 (fr) 2009-09-11

Family

ID=41056268

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2717481A Abandoned CA2717481A1 (fr) 2008-03-04 2008-03-04 Procedes pour inhiber la croissance de cellules tumorales a l'aide d'inhibiteurs de la pompe a protons

Country Status (9)

Country Link
EP (1) EP2254557A4 (fr)
JP (1) JP2011513396A (fr)
KR (1) KR20100123750A (fr)
AU (1) AU2008352018A1 (fr)
CA (1) CA2717481A1 (fr)
IL (1) IL207749A0 (fr)
MX (1) MX2010009795A (fr)
NZ (1) NZ587941A (fr)
WO (1) WO2009110862A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2548555A1 (fr) * 2011-07-18 2013-01-23 Fondazione IRCCS Istituto Nazionale dei Tumori Inhibiteurs de pompe à protons en tant qu'immunomodulateurs
CN113667646A (zh) * 2021-08-27 2021-11-19 潘思源 一种肾癌索拉非尼耐药细胞株及其构建方法和应用
WO2023048508A1 (fr) * 2021-09-23 2023-03-30 국립암센터 Composition pharmaceutique destinée à la prévention ou au traitement du cancer, contenant une matière brunie d'oméprazole
CN115475166B (zh) * 2022-09-13 2023-11-21 中南大学湘雅医院 瑞伐拉赞类化合物的应用、药物及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002080917A1 (fr) * 2001-04-06 2002-10-17 Forskarpatent I Uppsala Ab Nouvelle utilisation d'inhibiteurs de la pompe a protons
KR20050055415A (ko) * 2003-12-08 2005-06-13 함기백 벤즈이미다졸 유도체를 유효성분으로 함유하는 항암제
GB0403165D0 (en) * 2004-02-12 2004-03-17 Ct Novel uses for proton pump inhibitors

Also Published As

Publication number Publication date
NZ587941A (en) 2012-11-30
IL207749A0 (en) 2010-12-30
EP2254557A4 (fr) 2011-03-30
AU2008352018A1 (en) 2009-09-11
EP2254557A1 (fr) 2010-12-01
JP2011513396A (ja) 2011-04-28
KR20100123750A (ko) 2010-11-24
MX2010009795A (es) 2010-12-21
WO2009110862A1 (fr) 2009-09-11

Similar Documents

Publication Publication Date Title
US20120322820A1 (en) Methods to inhibit tumor cell growth by using proton pump inhibitors
RU2757373C2 (ru) Комбинированная терапия противоопухолевым алкалоидом
EP3013335B1 (fr) Polythérapie destinée au traitement du cancer contenant d'éribuline et du lenvatinib
WO2004043389B1 (fr) Procedes de traitement du cancer et procedes connexes
US20160324829A1 (en) Combination therapy with parp inhibitors
JP5642892B2 (ja) 多形膠芽腫の治療のためのマシテンタンを含有する組み合わせ剤
CA2717481A1 (fr) Procedes pour inhiber la croissance de cellules tumorales a l'aide d'inhibiteurs de la pompe a protons
JP2008505139A (ja) 悪心および嘔吐の処置における置換２−チオ−３，５−ジシアノ−４−フェニル−６−アミノピリジン類の使用
EP3331509B1 (fr) Solution injectable liquide stable de midazolam et de pentazocine
US20120053559A1 (en) Treatment of Proliferative Diseases with Epothilone Derivatives and Radiation
US20080207644A1 (en) Therapeutic materials and methods
US6426369B1 (en) Oxethazaine as antimicrobial agent
CN108703968B (zh) 左旋千金藤啶碱用于抑制或治疗转移性乳腺癌的用途
US20080280867A1 (en) Combination therapy with parp inhibitors
CN107137403B (zh) 一种pi3k/mtor抑制剂在制备治疗胰腺癌的药物中的用途
KR20100058662A (ko) 개에게서 림프종을 치료하기 위한 이다루비신
JP2000080031A (ja) 抗菌剤

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20140709